ArticleHormones (Athens, Greece)2026
Association of body composition with all-cause mortality among U.S. adults with osteoporosis or osteopenia: a population-based study.
Article in Hormones (Athens, Greece), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAdults with osteopenia or osteoporosis have increased risks of adverse outcomes; however, mortality risk varies substantially and may be influenced by body composition. Evidence for the joint impact of low muscle mass and percentage-based adiposity in this population remains limited.
objectivesTo examine the independent and combined associations of low muscle mass and obesity with all-cause mortality among U.S. adults with osteopenia or osteoporosis and to characterize the dose-response relationship between total fat mass and mortality.
methodsWe performed a retrospective cohort analysis of NHANES cycles with concurrent whole-body DXA (appendicular lean mass and total fat mass) and site-specific BMD assessments (1999-2006, 2013-2014, and 2017-2018). Eligible participants with osteopenia or osteoporosis and mortality linkage were included (unweighted n = 3,918). Low muscle mass (LMM) was defined by DXA-derived appendicular lean mass index (ALMI; men < 7.0 kg/m², women < 5.5 kg/m²), while obesity was operationally defined by DXA body fat percentage (FM%; men > 30%, women > 42%) instead of body mass index (BMI). Survey-weighted Cox models and restricted cubic splines were utilized.
resultsOver a median follow-up of 14.8 years, 1,095 deaths occurred. In fully adjusted models, low muscle mass was associated with higher mortality (HR = 1.59, 95% CI: 1.30-1.95). Jointly, both low muscle mass alone (HR = 1.70, 95% CI: 1.30-2.23) and low muscle mass with obesity (HR = 1.45, 95% CI: 1.13-1.87) were associated with higher mortality compared with the normal phenotype, whereas obesity alone was not; notably, the isolated low muscle mass phenotype exhibited a higher point estimate than the combined phenotype. For total fat mass, with Q1 as reference, intermediate quartiles exhibited significantly lower risk (Q2: HR = 0.71, 95% CI: 0.57-0.88; Q3: HR = 0.68, 95% CI: 0.54-0.87), while Q4 showed a similar but non-significant downward trend (HR = 0.64, 95% CI: 0.50-1.03).
conclusionsAmong U.S. adults with osteopenia or osteoporosis, low muscle mass was a robust predictor of all-cause mortality. Adiposity defined by body fat percentage was not independently associated with mortality, and fat mass demonstrated a nonlinear pattern with the lowest risk at intermediate levels. These findings support incorporating muscle assessment and refined adiposity measures into risk stratification beyond BMD alone. CLINICAL
trial registrationNot applicable.
Indexed as
Identifiers
42726194What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.